BridgeMD
Tests treatment safety and results for OAG - Open-Angle Glaucoma
Official title Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects With Open-Angle Glaucoma
ClinicalTrials.gov ID: NCT05696561
What this study is testing
- What it's testing
- Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects with Open-Angle Glaucoma
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 22 and older
You may be able to join if
- people qualifying for cataract surgery
- people with diagnosis of open-angle glaucoma in at least one eye with unmedicated IOP of 22-34 mmHg.
You likely can't join if
- 1\. Patients who cannot be washed-out of IOP-lowering medications.
The study team makes the final eligibility decision.
Where it's taking place
- Santiago, Chile
- San José, Costa Rica
- Santa Rosa de Copán, Honduras
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 22 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Santiago, Chile; San José, Costa Rica; Santa Rosa de Copán, Honduras. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.